-
CTN Youth SIG Webinar: The Power of Play: Using Digital Health Games to Target Adolescent Substance Use and Mental Health (March 15, 11am ET)
The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: The Power of Play: Using Digital Health Games to Target Adolescent Substance Use and Mental Health Presenter: Lynn Fiellin, M.D. Friday, March 15th, 2024 (11:00 a.m.–12:00 p.m. ET)Join Zoom MeetingMeeting ID: 977 1685 1154Passcode: 832521 This presentation will highlight the work of the play2PREVENT Lab, an academic games research program, and the use of serious videogame interventions to impact health outcomes, particularly substance use and mental health, in adolescents. This talk will outline the process and outcomes involved with the past 15 years of this NIH-funded research. About the presenter Dr. Lynn Fiellin is a Professor of Biomedical Data Science and the Center for Technology & Behavioral Health at Dartmouth College, Professor Adjunct at Yale, and the Founding Director of the play2PREVENT (p2P) Lab where she and her team focus on developing and evaluating digital health games. These games, as “serious videogames,” impact the health and well-being of adolescents, including opioid misuse, smoking/vaping, mental health, and sexual health. Most recently, she founded a new company, Playbl, that focuses on the broad-scale marketing and distribution of the 5 videogames developed and evaluated by the Lab. Upcoming Youth SIG Seminar Speakers in 2024 (all times are at 11am-12pm ET):May 17 – Dr. Kammarauche AneniSept 20 – Dr. Sivabalaji KaliamurthyNov 15 – Dr. Velma Murry
-
REMINDER for CTN Members: The Publications Subcommittee Needs One Month Notice for Review!
The Publication Committee would like to remind authors that papers, presentations, posters, workshops and abstracts should be submitted to the Publications Committee for prior review and approval at least a month in advance of submission to journals or conferences. Also, the Publication Committee welcomes volunteers to serve as protocol review team members for ongoing CTN studies. Please email Jack Blaine (jblaine@nih.gov) and Susan Sonne (sonnesc@musc.edu). Thank you.
-
New Year, New Look for the CTN Bulletin!
The CTN Bulletin is now using the MailChimp platform! MailChimp has several benefits over our previous method for these messages: If you have any questions, comments, or challenges with the new format, please let us know! Email us at ctnlib@uw.edu. Subscribe to the CTN Bulletin here!
-
NIDA CTN DI Mentor-Facilitated Training Awards Develop Future Leaders in SUD Education
Since 2012, the National Institute on Drug Abuse Clinical Trials Network Dissemination Initiative (NIDA CTN DI) Mentor-Facilitated Training (MFT) awards have supported health care trainees in the dissemination of best practices in substance use disorder (SUD) screening, prevention, and treatment. Physicians, physician associates, nurses, nurse practitioners, and pharmacists across the country have benefited from the program, which funds year-long, mentored dissemination projects. MFT awardees identify gaps in evidence-based SUD knowledge and treatment delivery, and address these gaps by creating trainings, workshops, and tools and resources for their colleagues and other providers in health care settings, schools, and communities. “Being a part of the MFT program opened my eyes to the gateway of publishing,” R. Shavon Clark, DNP, APRN, AGNP, says. Clark had not considered a career path that included investigation and publishing before she participated in the 2022 MFT program. Her project focused on screening pregnant women for substance use disorders. After distributing her project beyond her institution to Healthy Start, Early Steps, Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), First 1000 Days, and three obstetrics and gynecology practices in her community, she used her MFT award as a springboard to a secondary project that was published in The Journal of Addictions Nursing. “The NIDA CTN MFT awards are developing future health care leaders in substance use disorder treatment,” says NIDA CTN DI Contracting Officer’s Representative Quandra Blackeney. Ongoing partnerships with health care associations serving trainees are vital to sustaining the MFT program. The 2024 MFT…
-
New in the Library, Dec. 2023-Jan. 2024
Here are the latest items added to the CTN Dissemination Library for December 2023 – January 2024 (this post will be updated as new items come in): Webinars Alliances to Disseminate Addiction Prevention and Treatment (ADAPT): A Learning Health System to Improve Evidence-based Practices and Treatment, presented by Matt Aalsma, PhD. (CTN Translation & Implementation SIG webinar, 2023) Human-Centered Implementation Science? Improving the Design and Adaptation of Our Best Interventions and Strategies, presented by Aaron Lyon, PhD. (CTN Translation & Implementation SIG webinar, June 2023) When to Start Caring About Implementability: Pretty Much Now, presented by Geoffrey Curran, PhD. (CTN Translation & Implementation SIG webinar, May 2023) Journal Articles Co-occurring Substance Use Disorders Among Patients with Opioid Use Disorder in Rural Primary Care Clinics. Zhu Y, et al. Journal of Substance Use & Addiction Treatment 2023 (in press). CTN-0102 Lessons Learned and Future Directions: A Scoping Review of American Indian and Alaska Native Participants in the National Drug Abuse Treatment Clinical Trials Network. Crouch MC, et al. Journal of Substance Use and Addiction Treatment 2023;153:209081. Updated on 1/10/2024
-
News from the Appalachian Node
A rural clinic in New Martinsville WV affiliated with the Appalachian Node and West Virginia University has been selected as a site in CTN-0102-XR study Rural Expansion of Medication Treatment for Opioid Use Disorder. This is a Randomized Controlled Pilot Trial of Extended-release Buprenorphine (XR-BUP) vs. Sublingual Buprenorphine-naloxone (SL-BUP) in rural settings. The study is anticipated to get underway in the first quarter of 2024. Posted on 1/10/2024
-
Primary Care SIG Webinar: Primary Care Practice Engagement: The SPARC Trial (Jan. 22, 12pm ET)
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) Practice-Based Research Network (PBRN) SIG is transitioning to a Primary Care SIG (revitalizing the PBRN into primary care focus). To launch this, the Primary Care SIG is hosting a webinar titled Primary Care Practice Engagement: The SPARC Trial to Increase Alcohol-Related Prevention and Treatment. This virtual meeting is scheduled for Monday, January 22, 2024 from 12:00 p.m.– 1:00 p.m. ET. Speaker: Kathy Bradley, M.D. (Health Systems Node) Description: Dr. Bradley will speak on her team’s experience engaging primary care clinics in the SPARC trial. SPARC used practice facilitation, EHR tools and performance feedback, to implement alcohol-related prevention and treatment across 25 primary care clinics: 3 pilot sites and 22 sites in a stepped wedge trial in which the implementation intervention increased alcohol screening, brief intervention, AUD diagnosis, and initiation of AUD treatment (but not treatment engagement). The trial has been described in multiple publications (main results Lee JAMA Internal Medicine 2023). This presentation will focus on overcoming challenges in implementing the intervention in primary care clinics. This meeting will be recorded. If you are interested, please join the webinar here (no registration required). Please contact Maria Prado pradom@uw.edu to be added to the calendar invite and for access to the meeting recording afterwards. If you have any questions about the meeting logistics, please contact CTNSupport@leedmci.com. If you have any questions about the webinar content, please contact Sebastian Tong setong@uw.edu. Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through…
-
News from the Greater Southern California Node
Awards Congratulations to Dr. Lillian Gelberg, Professor in the Department of Family Medicine and Health Policy and Management, UCLA, for receiving the 2023 Maurice Wood Award for Lifetime Contribution to Primary Care Research! The Wood Award is given annually to honor a researcher who has made outstanding contributions to primary care research. Among Gelberg’s achievements are her pioneering research on health disparities, including work that helps people who are experiencing homelessness, as well as her efforts to integrate behavioral health into primary care, such as patient-centered approaches to prevent substance use disorders in low-income patients of federally qualified health centers. Publications
-
News from the New England Consortium Node
E. Jennifer Edelman, MD, MHA, was elected to the American Society for Clinical Investigation (ASCI). The ASCI is a prestigious honor society for physician-scientists. Founded in 1908, the ASCI is one of the nation’s oldest medical honor societies and is among the few organizations focused on the special role of physician-scientists in research, clinical care, and medical education, as well as leadership positions in academic medicine and the life sciences industry. Roger Weiss, MD, delivered the Eric D. Hadar Distinguished Lecture in Psychiatry at Columbia University on 11/15/2023 on “Integrating Pharmacotherapy and Behavioral Therapy in Treating Patients with Substance Use Disorders.” Roger Weiss, MD, received the Founders Award from the American Academy of Addiction Psychiatry (AAAP) on 12/8/2023 https://www.aaap.org/about/awards/. The AAAP Founders’ Award is presented by the organization to an outstanding member of the community who works in the field of addiction and who has contributed significantly to the science, teaching, treatment or public policy in the addictions. Shelly Greenfield, MD, MPH, was the recipient in 2022, and she presented the award and interviewed Dr. Weiss in a “fireside chat.” Photo: Front and center are Dr. Greenfield and Dr. Weiss with current and former MGB addiction psychiatry fellows (and some former MGH/McLean residents) who trained with them. Posted 12/18/2023
-
CTN Youth SIG Webinar: Youth Perspectives on Fentanyl (Jan. 19, 11am ET)
The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: Title: Unveiling Youth Perspectives on Fentanyl and the Adolescent Inpatient Addiction Treatment Landscape in the U.S.Presenters: Todd Korthuis, MD, MPH and Erin Stack, MSDate: Friday, January 19th, 2024 (11:00 a.m.–12:00 p.m. ET)Join Zoom Meeting: https://dartmouth.zoom.us/j/91937382102?pwd=OXJyK3NCOE1LaTZtQkVQUm42WlJhQT09Zoom Meeting ID: 919 3738 2102Passcode: 284403 Dr. Todd Korthuis is Professor of Medicine and Addiction Medicine Section Head at Oregon Health & Science University. He conducts addiction health services research and serves as Co-PI of the Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) Ms. Erin Stack has 15 years of experience supporting and leading research and evaluation projects, with expertise in community-based approaches. Trained as a community psychologist, her research focuses on promoting community health, equity, and safety, and more recently on understanding the needs of people with substance use disorders. In their complimentary presentation, Ms. Stack will showcase descriptive results from the Oregon Youth and Young Adult Fentanyl Survey, conducted to understand youth and young adults’ knowledge, beliefs, and behaviors related to fentanyl and counterfeit pills. Dr. Korthuis will share availability and cost of adolescent inpatient addiction treatment programs in the U.S. and describe treatment services offered at U.S. inpatient addiction treatment programs. Posted 12/18/2023
